Search

Author/Creator Bacchetta, Rosa

1. 146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1. (9th November 2020)

Authors:
Cepika, Alma-Martina; Chen, Pauline P; Uyeda, Molly; Cieniewicz, Brandon; Narula, Mansi; Amaya, Laura; Louis, David M; Xu, Liwen; Ji, Xuhuai; Bertaina, Alice; Agarwal-Hashmi, Rajni; Davis, Mark M; Meyer, Everett; Bacchetta, Rosa; Roncarolo, Maria Grazia
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1. (9th November 2020)

Authors:
Cepika, Alma-Martina; Chen, Pauline P; Uyeda, Molly; Cieniewicz, Brandon; Narula, Mansi; Amaya, Laura; Louis, David M; Xu, Liwen; Ji, Xuhuai; Bertaina, Alice; Agarwal-Hashmi, Rajni; Davis, Mark M; Meyer, Everett; Bacchetta, Rosa; Roncarolo, Maria Grazia
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Human‐engineered Treg‐like cells suppress FOXP3‐deficient T cells but preserve adaptive immune responses in vivo. Issue 11 (25th November 2020)

Authors:
Sato, Yohei; Passerini, Laura; Piening, Brian D; Uyeda, Molly Javier; Goodwin, Marianne; Gregori, Silvia; Snyder, Michael P; Bertaina, Alice; Roncarolo, Maria‐Grazia; Bacchetta, Rosa
Journal:
Clinical & translational immunology
Issue:
Volume 9:Issue 11(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗